- Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period
-
Song DS, Bae SH
- KMID: 1392904
- Clin Mol Hepatol.
- 2012 Sep;18(3):258-267.
- doi: 10.3350/cmh.2012.18.3.258
Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths in the world. There have been many advances in the diagnosis of HCC during the last ten years,... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Hepatocellular Carcinoma Combined with Liver Abscess
-
Yeom JO, Yoon SB, Kim JG, Oh JH, Jeon EJ, Jeong JJ, Choi SW, Lee S
- KMID: 1792756
- Korean J Gastroenterol.
- 2009 Jun;53(6):378-382.
- doi: 10.4166/kjg.2009.53.6.378
Hepatocellular calcinoma (HCC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. It is important to diagnose HCC exactly before management is attempted. But,... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy
-
Yoon I, Yim HJ, Kim JN, Park SM, Kim JH, Lee SH, Chung HH, Lee HS, Lee SW, Choi JH
- KMID: 1776819
- Korean J Hepatol.
- 2009 Mar;15(1):90-95.
- doi: 10.3350/kjhep.2009.15.1.90
Portal vein invasion is a grave prognostic indicator in the setting of hepatocellular carcinoma (HCC). There is currently no effective method for preventing the invasion of HCC into the main... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Serum alpha-fetoprotein (AFP) as a Marker for Hepatocellular Carcinoma (HCC) in Hepatitis C Virus Related Cirrhosis: Analysis of the Factors Influencing AFP Elevation without HCC Development
-
Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS
- KMID: 1113479
- Korean J Gastroenterol.
- 2006 Nov;48(5):321-326.
BACKGROUND/AIMS: Serum alpha-fetoprotein (AFP) is frequently used for the diagnosis of hepatocellular carcinoma (HCC). Most available data concerning AFP came from studies of patients with chronic hepatitis B or... -
- CITED
-
- Close
- SHARE
-
- Close
- Validation of P2/MS for reflecting hepatic fibrosis in patients with hepatocellular carcinoma
-
Yu SJ, Lee JH, Chung GE, Lee CH, Cho EJ, Jang ES, Kwak MS, Kim YJ, Yoon JH, Jang JJ, Lee HS
- KMID: 1117696
- Korean J Hepatol.
- 2010 Dec;16(4):389-396.
- doi: 10.3350/kjhep.2010.16.4.389
BACKGROUND/AIMS: P2/MS is known as a simple, accurate, and noninvasive marker for determination of the degree of hepatic fibrosis in patients with viral hepatitis. We aimed to validate P2/MS in... -
- CITED
-
- Close
- SHARE
-
- Close
